Table 3.

Comparison of sub-basal nerve plexus densities of patients during the aromatase inhibitor therapy.

	Pre-treatment (n = 13 eyes) Median (min-max)	At 3. month (n = 13 eyes) Median (min-max)	At 6. month (n = 13 eyes) Median (min-max)	P
Number of long nerves fibres, nerves/frame	3 (2–6)	2 (1–6)	2 (1–4)	<0.001*
Total number of nerves, nerves/frame	5 (2–8)	4 (2–7)	4 (2–5)	<0.001*
Total nerve density, mm/frame	1148.87 (955.32–3184.74)	1065 (629.52–2543.45)	995.56 (543.49–2245.56)	<0.001*
Tortuosity	1 (1–1)	1 (1–2)	2 (1–2)	0.004*

*Statistically significant.